Regulatory-aligned models MatTek provides 3D reconstructed human tissue models (skin, ocular, respiratory) that are used in regulatory toxicology across OECD and EU guidelines, presenting a strong sales angle to cosmetics, chemical, pharmaceutical, and household product companies seeking human-relevant alternative assays.

Global production footprint With tissue production facilities in the U.S., Europe, and China, MatTek offers scalable, globally deployable tissue models and potential regional partnerships to support multinational customers with consistent results and faster time-to-activity.

Wound-healing capability Recent development of in vitro wound healing models using EpiDermFT enables quantitative assessment of cutaneous re-epithelialization, opening up cross-selling opportunities with dermatology, cosmetic reformulation, wound care, and regenerative medicine segments.

Industry collaboration Active engagement in events (ESTIV Congress, SOT, Suppliers' Day) and collaboration initiatives (with Charles River Laboratories) indicate opportunities to co-market, co-develop, and access broader customer networks seeking NAMs and human-relevant data.

Acquisition-driven expansion Recent acquisition by Sartorius signals potential for expanded distribution, co-development, and bundled offerings through a larger portfolio, enabling cross-sell to existing Sartorius customers and leveraging Sartorius’ sales channels.